How to Check Rubicon Research IPO Allotment Scheduled for October 14?

Rubicon Research Ltd is set to finalise the IPO allotment on Tuesday, October 14, after receiving an overwhelming response from investors. The ₹1,377.5 crore Rubicon Research IPO is a book-built issue, comprised a fresh issue of 1.03 crore equity shares aggregating to ₹500 crore, along with an Offer for Sale (OFS) of 1.81 crore shares worth ₹877.5 crore.
Massive Subscription Across Categories
The IPO was open for bidding from October 9 to October 13 and witnessed robust participation across investor categories. The issue was subscribed to an impressive 103.89 times, with nearly 171 crore shares bid against the total offer of 1.64 crore shares.
- Retail Investors subscribed 35.47 times their quota
- Non-Institutional Investors (NIIs) saw a subscription of 97.61 times
- Qualified Institutional Buyers (QIBs) led the demand with 130.26 times subscription
- The Employee quota was oversubscribed by 16.80 times
Use of Funds
Rubicon Research will allocate ₹310 crore from the net proceeds towards repayment or prepayment of certain outstanding borrowings. The remaining funds will support inorganic growth through acquisitions, other strategic initiatives, and general corporate purposes.
Rubicon Research IPO Allotment: How to Check
Investors can check their allotment status through the BSE, NSE, or the official portal of the registrar, MUFG Intime India Pvt. Ltd using the following steps:
On BSE Website
- Visit: BSE Allotment Page
- Select ‘Equity’ as the issue type
- Choose ‘Rubicon Research Ltd’ from the dropdown
- Enter your Application Number or PAN
- Click on ‘Search’ to view your allotment status
On MUFG Intime India Website
- Visit: MUFG IPO Allotment Page
- Select ‘Rubicon Research Ltd’ from the dropdown list
- Choose one of the following: PAN, Application No., DP/Client ID, or Account No./IFSC
- Fill in the required details
- Click ‘Submit’ to view your allotment
Listing & Refund Timeline
- Credit of shares to demat accounts: Wednesday, October 15
- Refunds for non-allottees: Initiated on the same day
- Listing on NSE & BSE: Thursday, October 16
Also Read: Canara Robeco IPO Allotment Status Today; Shares to Be Credited on Oct 15
About Rubicon Research Ltd.
Established in 1999, Rubicon Research is a pharmaceutical company specialising in the development, manufacture, and commercialisation of differentiated formulations. With a focus on innovation and quality, the company serves global markets across multiple therapeutic areas.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Oct 14, 2025, 9:26 AM IST

Sachin Gupta
Sachin Gupta is a Content Writer with 6+ years of experience in the stock market, including global markets like the US, Canada, and Australia. At Angel One, Sachin specialises in creating financial content that simplifies complex market trends. Sachin holds a Master's in Commerce, specialising in Economics.
Know MoreWe're Live on WhatsApp! Join our channel for market insights & updates
- Upcoming IPOs This Week (August 10 – 14): Dhoot Transmission, Milky Mist Dairy Food, and Others
- NSE IPO: Why Has SBI Split Its Stake Sale, and What Does It Mean for Investors?
- Table Space Technologies Files DRHP for ₹800 Crore IPO, Plans Debt Repayment
- Behari Lal Engineering IPO Price Band Fixed at ₹271–₹285; Issue Opens on August 12, 2026
- SEBI FY26 Report: India Tops Global IPO Count, Ranks Third in IPO Fundraising



